A recent NIH-funded clinical trial compares treatments for complication of inflammatory eye disease and represents the first head-to-head comparison of Kenalog, Triesence and Ozurdex.

Macular oedema is a significant structural ocular complication of uveitis, which causes loss of visual acuity.

Please sign in to read more